TCL Archive Wyden Hearing On Taxol Agreements Mangles Facts In Attempt To Protect ‘Public Interest’ August 9, 1991
TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
TCL Archive ASCO Highlights Six Studies From Meeting To Showcase Advances In Cancer Care May 30, 2008
